Thomas Templeman's Net Worth
$1.59 Million
Who is Thomas Templeman?
Thomas Templeman has an estimated net worth of $1.59 Million. This is based on reported shares across multiple companies, which include Nuvation Bio Inc., Centessa Pharmaceuticals plc, and MEDIVATION, INC..
SEC CIK
Thomas Templeman's CIK is 0001654274
Past Insider Trading and Trends
2021 was Thomas Templeman's most active year for acquiring shares with 4 total transactions. Thomas Templeman's most active month to acquire stocks was the month of January. 2022 was Thomas Templeman's most active year for disposing of shares, totalling 4 transactions. Thomas Templeman's most active month to dispose stocks was the month of August. 2021 saw Thomas Templeman paying a total of $5,000.00 for 1,298,458 shares, this is the most they've acquired in one year. In 2022 Thomas Templeman cashed out on 12,761 shares for a total of $49,773.10, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Nuvation Bio Inc. (NUVB) Snapshot price: $1.64
SVP, Pharmaceutical Ops
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Centessa Pharmaceuticals plc (CNTA) Snapshot price: $8.15
Chief Technology Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -2.13% | -4.10K |
$3.90 | -$16,001.70 | 188.24K |
Mar 31
| |||
Form 4
| +45.78% | 60.4K |
—
|
—
| 192.35K |
Feb 1
| |||
Form 4
| -3.84% | -5.38K |
$4.25 | -$22,873.50 | 134.87K |
Sep 30
| |||
Form 4
| -2.08% | -2.92K |
$3.10 | -$9,055.10 | 137.33K |
Dec 31
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| -3.18% | -4.46K |
$4.00 | -$17,844.50 | 135.79K |
Sep 30 - Oct 3
| |||
Form 4
| +56,000.00% | 140K |
—
|
—
| 140.25K |
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
|
∞
| 250 |
$20.00 | $5,000.00 | 250 |
Apr 20 - Jun 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
MEDIVATION, INC. No price found
SVP, Pharmaceutical Operations
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 22.72K |
—
|
—
| 22.72K |
Sep 29 - Sep 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||